2. Academic Validation
  3. Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase

Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase

  • J Med Chem. 2007 Apr 19;50(8):1727-30. doi: 10.1021/jm0700619.
Michael N Greco 1,  Michael J Hawkins,  Eugene T Powell,  Harold R Almond Jr,  Lawrence de Garavilla,  Jeffrey Hall,  Lisa K Minor,  Yuanping Wang,  Thomas W Corcoran,  Enrico Di Cera,  Angelene M Cantwell,  Savvas N Savvides,  Bruce P Damiano,  Bruce E Maryanoff
Affiliations

Affiliation

  • 1 Research and Early Development, Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania 19477-0776, USA. mgreco@prdus.jnj.com
PMID: 17361995 DOI: 10.1021/jm0700619
Abstract

A series of beta-carboxamido-phosphon(in)ic acids (2) was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase. For example, 1-naphthyl derivative 5f had an IC50 value of 29 nM and (E)-styryl derivative 6g had an IC50 value of 3.5 nM. An X-ray structure for 5f.chymase revealed key interactions within the Enzyme active site. Compound 5f was selective for inhibiting chymase versus eight serine proteases. Compound 6h was orally bioavailable in rats (F=39%), and orally efficacious in a hamster model of inflammation.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z